Revolutionizing Alzheimer’s diagnosis: New insights into blood-brain barrier biomarkers

Alzheimer's

Alzheimer’s disease, the most prevalent form of dementia, involves the disruption of the blood-brain barrier (BBB), a critical defense mechanism of the brain. Recent research has identified unique molecular changes in the BBB that could pave the way for groundbreaking diagnostic and therapeutic approaches. Understanding the blood-brain barrier’s role in Alzheimer’s The BBB is composed […]

New blood test shows promise in diagnosing neurodegenerative diseases

blood test

Researchers have discovered a blood marker that could revolutionize the diagnosis of certain neurodegenerative diseases, including frontotemporal dementia (FTD), amyotrophic lateral sclerosis (ALS), and progressive supranuclear palsy (PSP). Key findings Blood markers can help diagnose neurodegenerative diseases. Currently, diseases like ALS are diagnosed by ruling out other conditions. Definitive diagnosis often occurs post-mortem. The study, […]